Profile data is unavailable for this security.
About the company
Entero Healthcare Solutions Limited is an India-based technology-driven and integrated healthcare products distribution company. It offers a range of pharmaceuticals and other healthcare products to approximately 86,200 retail pharmacies and healthcare practitioners (HCPs) across 492 districts in India. Its portfolio includes over 68,900 SKUs from more than 2000 pharma companies. The Company is a supplier to over 3,500 hospitals across India, including corporate hospital chains. It has over a network of 104 warehouses. Its technology solutions include Entero Direct, Entero CRM, Entero ERP, and Teqtic. Its Entero Direct platform is a cloud-based software-as-a-service solution that allows retailers to order their procurement needs. The Entero CRM application is a customer relationship management tool that manages and analyzes its interactions with customers, in order to customer retention and wallet share. It also offers its products through the Aayu Chemist app and Medcords platform.
- Revenue in INR (TTM)60.20bn
- Net income in INR1.13bn
- Incorporated2018
- Employees4.11k
- LocationEntero Healthcare Solutions LtdUnit No. 605 & 6066th Floor,, Trade Centre,, Bandra KurlaMUMBAI 400051IndiaIND
- Phone+91 2 269019100
- Websitehttps://www.enterohealthcare.com/
Mergers & acquisitions
| Acquired company | ENTERO:NSI since announced | Transaction value |
|---|---|---|
| Bioaide Technologies Pvt Ltd | 2.42% | 4.07m |
| Anand Chemiceutics Pvt Ltd | 2.42% | 26.01m |
| Ace Cardiopathy Solutions Pvt Ltd | 2.58% | 8.70m |
| Ramson Medical Distributors Pvt Ltd | -24.55% | 835.00k |
| Anand Medical Distributors Pvt Ltd | -24.55% | -- |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Laxmi Dental Ltd | 2.65bn | 231.81m | 10.00bn | 2.01k | 41.24 | -- | 28.48 | 3.78 | 4.41 | 4.41 | 50.62 | -- | -- | -- | -- | 1,313,650.00 | -- | -- | -- | -- | 72.31 | -- | 7.30 | -- | -- | 3.09 | -- | -- | 23.53 | -- | 23.13 | -- | -- | -- |
| Tarsons Products Ltd | 4.14bn | 203.44m | 10.54bn | 906.00 | 51.80 | -- | 9.77 | 2.54 | 3.82 | 3.82 | 78.03 | -- | -- | -- | -- | 4,572,594.00 | -- | -- | -- | -- | 67.27 | -- | 4.91 | -- | -- | 1.54 | -- | -- | 32.40 | -- | -30.18 | -- | -- | -- |
| Borosil Scientific Ltd | 4.54bn | 160.74m | 10.66bn | 631.00 | 66.32 | -- | 30.35 | 2.35 | 1.81 | 1.81 | 50.94 | -- | -- | -- | -- | 7,189,503.00 | -- | -- | -- | -- | 62.77 | -- | 3.52 | -- | -- | 21.06 | -- | -- | 11.13 | -- | 13.77 | -- | -- | -- |
| Fischer Medical Ventures Ltd | 2.60bn | 394.51m | 26.84bn | 40.00 | 77.51 | -- | 63.87 | 10.32 | 0.5338 | 0.5338 | 1.38 | -- | -- | -- | -- | 65,004,850.00 | -- | 0.9236 | -- | 1.12 | 56.38 | -- | 15.17 | 2.21 | -- | 15.69 | -- | -- | 427.61 | -- | -34.28 | -- | -- | -- |
| Entero Healthcare Solutions Ltd | 60.20bn | 1.13bn | 47.76bn | 4.11k | 42.44 | -- | 28.24 | 0.7933 | 25.86 | 25.86 | 1,381.13 | -- | -- | -- | -- | 14,644,470.00 | -- | 1.24 | -- | 1.91 | 10.03 | 8.62 | 2.19 | 0.5496 | -- | 4.03 | -- | -- | 29.92 | 30.44 | 142.45 | 151.43 | -24.11 | -- |
| Poly Medicure Ltd. | 17.82bn | 3.48bn | 131.85bn | 3.08k | 38.13 | -- | 29.59 | 7.40 | 34.11 | 34.11 | 174.83 | -- | -- | -- | -- | 5,780,584.00 | -- | 13.20 | -- | 15.82 | 68.23 | 55.88 | 19.51 | 18.03 | -- | 45.32 | -- | 12.84 | 21.37 | 19.43 | 31.09 | 28.70 | 25.57 | 11.84 |
| Holder | Shares | % Held |
|---|---|---|
| OrbiMed Advisors LLCas of 30 Jun 2025 | 16.54m | 38.01% |
| ICICI Prudential Asset Management Co. Ltd. (Invt Mgmt)as of 29 Dec 2025 | 2.18m | 5.02% |
| Invesco Asset Management (India) Pvt Ltd.as of 31 Jan 2026 | 2.07m | 4.75% |
| GIC Pte Ltd. (Investment Management)as of 11 Aug 2025 | 1.37m | 3.14% |
| APG Asset Management NVas of 30 Jun 2025 | 959.57k | 2.21% |
| Jupiter Asset Management Ltd.as of 31 Oct 2025 | 441.19k | 1.01% |
| Mackenzie Investments Asia Ltd.as of 30 Nov 2025 | 209.45k | 0.48% |
| HSBC Asset Management (India) Pvt Ltd.as of 31 Dec 2025 | 122.86k | 0.28% |
| Motilal Oswal Asset Management Co. Ltd.as of 31 Dec 2025 | 55.78k | 0.13% |
| C WorldWide Asset Management Fondsm�glerselskab A/Sas of 30 Jun 2025 | 53.04k | 0.12% |
